Hims & Hers stock experienced over 30% decline after key partner announcement
From Nasdaq, Inc.: 2025-06-27 03:33:00
- A growth stock experienced a significant decline in stock price following an announcement with a key partner on June 25, 2025. (*Stock prices used were the afternoon prices of June 23, 2025)
- The Motley Fool Stock Advisor team identified the 10 best stocks to buy right now, but Hims & Hers Health didn’t make the cut. The top 10 list could produce monster returns, with historical examples like Netflix and Nvidia. Stock Advisor’s total average return is 818%, outperforming the S&P 500. Join Stock Advisor to access the latest top 10 list. (*Stock Advisor returns as of June 23, 2025)
- Parkev Tatevosian, CFA, has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. Tatevosian may be compensated for promoting services, but his opinions remain his own. (*Disclaimer: The views expressed are those of the author and do not necessarily reflect those of Nasdaq, Inc.)
Read more at Nasdaq, Inc.: Down Over 30%, What’s Going on With Hims & Hers stock?